FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileOsteopore Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OSX.AX
Osteopore Limited Stock AnalysisComprehensive stock analysis for Osteopore Limited (OSX.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisOSX.AX
OSX.AX
Osteopore Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
OSX.AX
  1. Home
  2. Stocks
  3. Osteopore Limited

Osteopore Limited

🇦🇺OSX.AX•ASX

Osteopore Limited

🇦🇺OSX.AX•ASX

Your view on OSX.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Osteopore Limited

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Yujing Lim
Headquarters
Level 5, 191 St. Georges Terrace, Perth, WA, AU
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Yujing Lim
Headquarters
Level 5, 191 St. Georges Terrace, Perth, WA, AU
Description

Established in Singapore in 2003, Osteopore Limited focuses on engineering, manufacturing, and globally commercializing bioresorbable polymer implants. These advanced devices are utilized in neurosurgical, orthopedic, and maxillofacial operations throughout Singapore, Australia, and other international regions.

The company's core innovation involves employing 3D printing with bioresorbable materials to create custom, micro-structured scaffolds specifically designed to foster bone regeneration.

Its product portfolio includes Osteoplug, a resorbable implant for sealing trephination burr holes during neurosurgery, and Osteomesh, another resorbable implant used in craniofacial surgery to mend various fractures, including orbital floor injuries, and to fill surgical voids.

Additionally, Osteopore has forged a collaborative partnership with Livingstone Health Holding Limited to jointly pioneer new products and applications for bone and tissue regeneration.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Osteopore Limited. Starting points for Osteopore Limited: EPS -AUD 0.0078, beta -0.02 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Osteopore Limited. Osteopore Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Osteopore Limited. Trailing twelve-month EPS for Osteopore Limited stands at -AUD 0.0078. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Osteopore Limited. Osteopore Limited has reported as a listed company since 2019. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold OSX.AX20 companies
Compare OSX.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
1AD.AXAdAlta LimitedHealthcareBiotechnology—
ACR.AXAcrux LimitedHealthcareBiotechnology—
ANR.AXAnatara Lifesciences LtdHealthcareBiotechnology—
BIT.AXBiotron LimitedHealthcareBiotechnology—
CTQ.AXCareteq LimitedHealthcareMedical - Healthcare Information Services—
EXL.AXElixinol Wellness LimitedHealthcareDrug Manufacturers - Specialty & Generic—
OAK.AXOakridge International LimitedHealthcareMedical - Healthcare Information Services—
TD1.AXTALi Digital LimitedHealthcareMedical - Healthcare Information Services—
More Medical - Instruments & Supplies companies
TickerTypeCompanySectorExchangeMkt cap
DGENDeltagen Inc.HealthcareOTC$3,859
DXRDaxor CorporationHealthcareNASDAQ$46.8M
ECIAEncision Inc.HealthcareOTC$1.9M
EKTAFElekta AB (publ)HealthcareOTC$2.2B
EKTAYElekta AB (publ)HealthcareOTC$2.5B
EMBCEmbecta Corp.HealthcareNASDAQ$345.1M
ESLOFEssilorLuxottica S.A.HealthcareOTC$128.6B
ESLOYEssilorLuxottica S.A.HealthcareOTC$129.8B
FEMYFemasys Inc.HealthcareNASDAQ$9.6M
FPH.AXFisher & Paykel Healthcare Corporation LimitedHealthcareASX—
FSPKFFisher & Paykel Healthcare Corporation LimitedHealthcareOTC$14.2B
GRRMFGerresheimer AGHealthcareOTC$691.8M
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Osteopore Limited. Coverage tracks Osteopore Limited within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Osteopore Limited.

OSX.AX AnalysisWeak
Past
1
Growth
1
Health
5
Profit
1
Value
1

News

Latest Market News